2Catenacci M,Sastry S,Falcone T. Laparoscopic surgery for en- dometriosis. Clin Obstet Gynecol, 2009,52(3) : 351-361.
3Petta CA, Ferriani RA, Abrao MS, et al. Randomizde clinicai trial of alevonorgestrel-releasing intrauterine system and a depot GnRH analogue forthe treatment of chronic pelvic pain in women with endometrisis. Hum Reprod,2005,20:1993-1998.
5Attaran M, Falcone T , Goldberg J. Endometriosis: still tough to diagnose and treat [J] . Cleve Clin J Med, 2002, 69 (8) : 647.
6Lahteenmaki P, Rauramo I, Baekman T. The levonorgestrel intrauterine system in contraception [J] . Steroid, 2000, 65:693.
7Cho S,Nam A,Kim H,et aL Clinical effects of the levonorgestrel-releasing intrauterine device in patients with adenomayosisFJ].Am J Obstet Gynecol,2008,198(1):1-7.
2ScarselliG, Bargelli G, Taddei G L, et aLLevonorgestrel-releasing intrauterine system ( LNG-IUS ) as an effective treatment option for endometrial hyperplasia: a 15-year follow-up study[J].Fertil Steril, 2011, 95 ( 1 ) : 420-422.
3Diana M.The benefits and risks of using a levonorgestrel-releasing intrauterine system for contraception[J].Contraception, 2012, 85 ( 3 ). 224-234.
4Lal S, Kriplarfi A, Kulshrestha V, et al.Efficacy of mifepristone in redueing intermenstrual vaginal bleeding in users of the levonorgestrel intrauterine system[J].Int J Gynaeeol Obstet, 2010, 109 ( 2 ) : 128- 130.
5Gardner FJ,Konje JC,Abrams KR,et al. Endometrial pro- tection from tamoxifen-stimulated changes by a lev- onorgestrel-releasing intrauterine system:a randomized controlled trial [J]. Lancet,2000,356(9243) : 1711-1717.
6Choi YS,Cho S,Lim KJ,et al. Effects of LNG-IUS on nerve growth factor and its receptors expression in patients with adenomyosis [J]. Growth Factors, 2010,28 (6) : 452-460.
7Engemise SL,Willets JM,Taylor AH,et al. Changes in glandular and stromal estrogen and progesterone receptor isoform expression in eutopic and ectopic endometrium following treatment with the levonorgestrel-releasing in- trauterine system [J]. Eur J Obstet Gynecol Reprod Biol, 2011,157 ( 1 ) : 101-106.
8Mansour D. The benefits and risks of using a levonorgestrel- releasing intrauterine system for contraception [J]. Contra- ception, 2012,85 (3) :224-234.
9Lal S,Kriplani A,Kulshrestha V,et al. Efficacy of mifepri- stone in reducing intermenstrual vaginal bleeding in users of the levonorgestrel intrauterine system [J]. Int J Gy- naecol Obstet ,2010,10(2) : 128-130.
